INVION LIMITED (IVX)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 2 signal(s) for IVX during the last 90 days, indicating Moderate trading activity

Latest IVX Signals
30/06/2026	SELL
19/05/2026	SELL
02/04/2026	SELL
IVX Share Price
Current Price	$0.032
52 Week High	$0.145
52 Week Low:	$0.032
Trading at (% of 52 Week High)	22.07%

Business Overview

Invion Limited (ASX: IVX) is an Australian company focused on developing and commercializing innovative therapies for the treatment of cancer and inflammatory diseases. The company utilizes advanced drug delivery technologies to create targeted treatment solutions.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for INVION LIMITED (IVX) is supported by weak price momentum and potential liquidity concerns at the current low price level. However, the confidence is moderated by limited available market data and potential volatility in small-cap stocks.

Latest  INVION LIMITED(IVX)   News